$IEX

IDEX (IEX) Q2 2026 Earnings Call Transcript

IDEX (IEX) reported Q2 2026 net sales of $920.6 million, up 6% reported and 5% organic. Adjusted diluted EPS rose 12% to $2.32. Orders were $1,071.6 million, a record, up 29% reported and 28% organic. Full-year 2026 guidance was raised: organic growth 5% to 6% and EPS $8.70 to $8.85.

Original reporting
Published Aug 16, 2026, 4:14 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 16, 2026, 6:40 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
IDEX (IEX) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$IEXBullishMed
01

Why it matters

Traders can update models around raised FY and Q3 guidance, assess earnings quality via tariff refund impact, and monitor segment mix risk (notably FMT margin down despite productivity benefits).

02

Market read

Guidance raises and record orders are the primary catalysts, with tariff refund benefit and segment mix providing the main uncertainty for follow-through.

03

What to watch

Forward visibility is improving, but the call also notes expected reductions in dispensing activity and softer European rescue markets, which could pressure organic growth if demand shifts.

Relevance 8/10Novelty 7/10Timing: post-earnings call, guidance update for FY 2026 and Q3 2026

Background

This is a transcript-style summary of IDEX’s Q2 2026 earnings call, including segment order growth, margin drivers, and updated 2026 guidance.

Company-level read

Ticker impact

$IEXBullishMedium confidence
Context

IDEX reported Q2 2026 net sales of $920.6M, record orders of $1,071.6M, and raised full-year EPS and organic growth guidance.

Expected impact

Bias upward for near-term positioning, but expect volatility around FMT margin mix and tariff/timing normalization.

Evidence & confidence

The article discloses multiple forward-looking datapoints (raised FY organic growth 5% to 6%, FY adjusted EPS $8.70 to $8.85, FY EBITDA margin 27% to 27.3%) alongside segment-level margin commentary (FMT down on unfavorable mix) and a specific tariff refund benefit ($0.08/share), which can temper quality of earnings.

Market effects

Signals continued strength in data center, semiconductor, and space and defense demand within industrial instrumentation, while water and rescue segments show more mixed margin dynamics.

Mentions softer European rescue market activity, implying uneven regional demand within FSDP.

Tariff resolution and IEEPA-related refund mechanics highlight ongoing trade-policy uncertainty affecting industrial margins.

Counterpoint

The raised outlook may be partially supported by tariff-related accounting benefits and favorable volume leverage, while FMT margin contraction flags underlying mix risk.

Key entities

  • IDEX Corporation

    Reported Q2 2026 results and raised full-year 2026 organic growth, adjusted EPS, and adjusted EBITDA margin guidance.

  • Eric Ashleman

    CEO who highlighted demand strength in data center, semiconductor, and space and defense within HST and discussed forward order visibility.

  • Sean Gillen

    CFO who discussed segment margin drivers, including FMT margin decline due to unfavorable mix and tariff refund effects.

Related articles

$IEXHighAI 9/10

IDEX (IEX) Q2 2026 Earnings Call Transcript

IDEX (IEX) Q2 2026 earnings call reported organic revenue growth of 5% and organic orders up 28%. HST led with 47% organic order growth and 12% organic revenue growth. Adjusted EPS was $2.32, above guidance $2.07 to $2.12, and adjusted EBITDA margin rose 70 bps. Free cash flow was $177M, liquidity over $1.1B, and $77M share repurchases. IEEPA tariff refunds added a $0.08 EPS benefit.

$IEXMed

IEX's plea against power exchange market coupling rejected by SC

India’s Supreme Court rejected Indian Energy Exchange (IEX)’s plea to stop CERC’s market coupling regulations for power exchanges, saying it was not the right stage because the rules are not yet finalized. The Court allowed CERC to continue drafting while noting it expressed no view on merits. IEX argued coupling would reduce competition and raised conflict-of-interest concerns.

$IEXHighAI 9/10

IDEX Raises Full-Year Outlook After Strong Second-Quarter Results

IDEX Corporation (NYSE:IEX) reported better-than-expected second-quarter earnings and revenue while raising its full-year guidance, sending the industrial technology company's shares nearly 4% higher in premarket trading on Wednesday. Adjusted earnings came in at $2.32 per share for the quarter ended June 30, exceeding the Wall Street consensus estimate of $2.11 by $0.21.

$IEXMedAI 8/10

IDEX Pops on Quarterly Figures

IDEX Corporation (NYSE: IEX) reported quarterly results for the three months ended June 30, 2026. The company said orders exceeded $1 billion, a record, and projected Q3 2026 organic sales growth of 5% to 7% and adjusted diluted EPS of $2.20 to $2.25. Net sales included a $14.7 million reduction from customer rebates tied to invalidated tariff refunds, and IDEX raised full-year guidance.

$IEXMedAI 8/10

IDEX Boosts FY26 Outlook; Shares Up 7% - Update

IDEX Corp. (IEX) reported Q2 results and raised its FY2026 outlook. For Q3, it guided adjusted EPS of $2.20 to $2.25 and organic net sales growth of about 5% to 7%. For FY2026, it now expects adjusted EPS of $8.70 to $8.85 with organic growth of 3% to 4%, versus prior $8.35 to $8.55. Shares were up about 7% premarket.